While common variants of UMOD are strongly associated with risk of chronic kidney disease, higher levels of a monomeric form of UMOD that circulates in the serum and regulates renal and systemic oxidative stress were recently linked to a lower risk for mortality and cardiovascular disease in older adults (LaFavers et al, 2019; Steubl et al, 2020). Here, UMOD is linked to chronic kidney disease.